Northwest Biotherapeutics reported $-0.01 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Agenus USD 1.02 1.32 Mar/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Celldex Therapeutics USD -0.94 0.24 Jun/2026
Eisai JPY 64.71 76.24 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Northwest Biotherapeutics USD -0.01 0 Mar/2026
Pfizer USD 0.77 0.02 Jun/2026
Plus Therapeutics USD -26.13 26.09 Mar/2026
Roche Holding CHF 10.98 2.61 Jun/2026